Skip to content
The Policy VaultThe Policy Vault

Cabometyx (cabozantinib) — Highmark

extra-pancreatic neuroendocrine tumors (epNET)

Initial criteria

  • age ≥ 12 years
  • diagnosis of unresectable, locally advanced or metastatic, well-differentiated epNET (ICD-10: C7A.8)
  • previously treated for epNET